FORMYCON
LIVE

Serial Number

79114441

Owner

Formycon AG

Filing Date

Nov 28, 2011

Add to watchlist:

No watchlists yet
View on USPTO

FORMYCON Trademark

Serial Number: 79114441 • Registration: 4290756

FORMYCON is a trademark filed by Formycon AG on November 28, 2011. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Formycon AG (2 trademarks)

Fraunhoferstraße 15
Martinsried/Planegg 82152 , DE

Entity Type: 99

Formycon GmbH

Frauenhoferstrasse 15
Planegg 82152 , DE

Entity Type: 16

Scil Technology GmbH

Fraunhoferstrasse 15

Entity Type: 16

Trademark Details

Filing Date

November 28, 2011

Registration Date

February 19, 2013

Published for Opposition

December 4, 2012

Cancellation Date

November 29, 2021

Goods & Services

Treatment of material, namely, coating by technological means of biomaterial and medical products; contract manufacturing services in the field of medical services especially for test samples for studies on animals and humans

Medicines for human and dental purposes, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations, namely, acne medications, hormones, medicinal herbs, allergy relief medication, antibiotics, anticoagulants, antidepressants, antihistamines, antiparasitics, aspirin

Consultancy services in relation to pharmacy and medicine

Services of a pharmaceutical laboratory, scientific research and development relating to chemistry, pharmacy and biotechnology; development of pharmaceuticals with emphasis on protein based medicinal formula and pharmaceutical products for others; development of pharmaceuticals for the regenerative therapy with emphasis on orthopedic and dental services for pharmaceutical clients and medical device manufacturers; services of a pharmaceutical laboratory, namely, evaluation and characterization of pharmaceuticals and medicinal formula; scientific and technological services and development of analytical examination, services of a pharmaceutical laboratory, chemical analysis, technological services, namely, the development of methods for the biochemical characterization of pharmaceuticals and medicinal formula and validation of these methods; quality and material control testing for others, namely, conducting processes for the verification of the stability and mutation of protein and active pharmaceutical ingredients; quality control for others, especially for test samples for studies on animals and humans; research services in relation to the manufacturing of pharmaceuticals; services of a pharmaceutical laboratory, namely, development services, especially process development for the manufacturing of pharmaceuticals and medicinal products and pharmaceutical formula; enhancement of existing medicinal formula and pharmaceutical formula; quality control testing, namely, process control for the quality assurance; scientific consultancy in relation to the before mentioned services; information services in relation to scientific research related to biochemistry and biotechnology; conducting medical and clinical tests in relation to pharmaceuticals

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Jun 20, 2022 DENC
DEATH OF INTERNATIONAL REGISTRATION
Jun 20, 2022 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Jul 17, 2020 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jun 18, 2020 INTS
INVALIDATION PROCESSED
Jun 18, 2020 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
May 20, 2020 INTR
CANCELLED SECTION 71
Sep 20, 2019 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Apr 18, 2019 NREP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 13, 2019 TCCA
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 19, 2018 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 15, 2013 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 25, 2013 FICS
FINAL DISPOSITION PROCESSED
Sep 25, 2013 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 19, 2013 FICR
CHANGE OF NAME/ADDRESS REC'D FROM IB
Apr 19, 2013 ADCH
REGISTERED-PRINCIPAL REGISTER
Feb 19, 2013 R.PR
NOTIFICATION PROCESSED BY IB
Jan 1, 2013 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 4, 2012 NPUB
PUBLISHED FOR OPPOSITION
Dec 4, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 14, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 14, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 14, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 30, 2012 PREV
ASSIGNED TO LIE
Oct 30, 2012 ALIE
CHANGE OF OWNER RECEIVED FROM IB
Oct 29, 2012 CHLD
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 16, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 15, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 15, 2012 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 15, 2012 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 7, 2012 GNFN
FINAL REFUSAL E-MAILED
Oct 7, 2012 GNFR
FINAL REFUSAL WRITTEN
Oct 7, 2012 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 11, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 11, 2012 TROA
REFUSAL PROCESSED BY IB
Aug 17, 2012 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 30, 2012 RFCS
REFUSAL PROCESSED BY MPU
Jul 30, 2012 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2012 RFCR
NON-FINAL ACTION WRITTEN
Jul 27, 2012 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 24, 2012 MAFR
ASSIGNED TO EXAMINER
Jul 20, 2012 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 20, 2012 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 19, 2012 REPR